CEPI Board
CEPI is a Norwegian Association and CEPI’s primary governing body is the CEPI Board. The Board has 12 voting members (four investors and eight independent members representing competencies including industry, global health, science, resource mobilisation, finance) and five observers. The Board is advised on decisions, such as prioritising pathogens and selecting partners, by our Scientific Advisory Committee.
Learn more
Board Committees
We have four Board Committees: Executive and Investment; Nominations, Compensation, Diversity and Inclusion; Audit and Risk; and Equitable Access. Other Board members or experts may be called upon as advisers or observers as needed.
Executive and Investment Committee
CEPI’s Executive and Investment Committee provides strategic guidance to the CEO and acts on behalf of the CEPI Board to support on matters including, but not limited to, responses to arising matters, time-sensitive decisions related to CEPI’s investment portfolio, approval of organizational policies, and ad-hoc funding requests and decisions up to an amount of US$50 million.
Nominations, Compensation, Diversity and Inclusion Committee
The responsibilities of CEPI’s Nominations, Compensation, Diversity and Inclusion Committee include, but are not limited to, reviewing total compensation for CEPI employees, nomination of Board Members, and supports CEPI’s work to develop a diverse and inclusive work force.
Audit and Risk Committee
The Audit and Risk Committee is involved in CEPI’s internal and external audit processes, and considers and monitors potential risks that may impact CEPI.
The Committee also reviews and monitors CEPI’s budget and financial activities and reviews and receives reports of activities relating to compliance, whistleblowing and fraud.
Equitable Access Committee
CEPI’s commitment to equitable access informs every aspect of our work. CEPI’s approach to enabling equitable access is guided by its Equitable Access Policy, and is overseen by the Equitable Access Committee.
